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Background: The purpose of this study was to develop folate-poly (PEG-cyanoacrylate-
co-cholesteryl cyanoacrylate) (FA-PEG-PCHL)-modified freeze-dried liposomes for targeted 
chemotherapy using docetaxel as a model drug.
Methods: FA-PEG-PCHL was synthesized and its cytotoxicity was evaluated by CCK-8 
assay in L929. Docetaxel-loaded liposomes modified by FA-PEG-PCHL were prepared by 
an organic solvent injection method and lyophilized to obtain freeze-dried FA-PEG-PCHL-
docetaxel liposomes (FA-PDCT-L). Two carcinoma cell lines (MCF-7 and A-549 cells) were 
cultured with docetaxel solution, conventional docetaxel-loaded liposomes, or FA-PDCT-L, 
and the cytotoxicity and apoptosis was evaluated for each preparation. The uptake of the 
docetaxel preparations into MCF-7 cells was studied by confocal laser scanning microscopy. 
Liquid chromatography-mass spectrometry was used to study the pharmacokinetics and tissue 
distribution characteristics of the preparations.
Results: The existence of an enlarged fixed aqueous layer on the surface of the liposomes was 
affirmed by zeta potential analysis. The entrapment efficiency and particle size distribution 
were almost the same as those of docetaxel-loaded liposomes. The drug release profile showed 
that the release rate was faster at higher molecular weight of the polymer. Compared with 
docetaxel solution and docetaxel-loaded liposomes, FA-PDCT-L demonstrated the strongest 
cytotoxicity against two carcinoma cell lines, the greatest intracellular uptake especially in the 
nucleus, as well as the most powerful apoptotic efficacy. In pharmacokinetic studies, the area 
under the plasma concentration-time curve of FA-PDCT-L was increased 3.82 and 6.23 times 
in comparison with the values for the docetaxel-loaded liposomes and docetaxel solution, 
respectively. Meanwhile, a lower concentration of docetaxel was observed for FA-PDCT-L in 
the liver and spleen, and a significantly higher concentration of FA-PDCT-L in tumors sug-
gested that the presence of FA-PEG-PCHL on the liposomes resulted in greater accumulation 
of the drug in tumor tissue.
Conclusion: Liposomes modified by FA-PEG-PCHL could be one of the promising suspen-
sions for the delivery of antitumor drugs in cancer.
Keywords: folate-poly (PEG-cyanoacrylate-co-cholesteryl cyanoacrylate), docetaxel, freeze-
dried liposomes, tumor targeting
Introduction
Nanotechnology has been extensively exploited to improve conventional cancer therapy 
recently.1,2 The nanocarriers currently under intensive investigation can be divided into 
two categories in general, ie, polymer-based and lipid-based polymeric nanoparticles and 
liposomes.3 The use of polymeric nanoparticles using biodegradable polymers, such as 
poly (D,L-lactic acid), poly (D,L-lactic-co-glycolic acid) and poly (3-caprolactone), and International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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their copolymers diblocked or multiblocked with   polyethylene 
glycol (PEG), for drug delivery has shown promising thera-
peutic potential.4–6 These nanoparticles have been widely 
used because of their high drug-loading capacity especially 
for hydrophobic drugs, controlled drug release, acceptable 
biocompatibility, high cellular internalization, and a long 
circulation half-life.2 However, polymeric nanoparticles 
have reported moderate circulation half-lives in comparison 
with their liposomal counterparts, even when coated with 
biocompatible polymers such as PEG.7
Liposomes are spherical vesicles composed of single 
or multiple lipid bilayers, and have a number of appealing 
features, including high biocompatibility, high delivery 
efficiency, a favorable pharmacokinetic profile, and ease of 
surface modification.8,9 The performance of liposome drug 
delivery systems for tumor therapy could be further improved 
by using a ligand coupled to the surface of vesicles to achieve 
an active targeting effect. The selective overexpression of 
folate receptors in tumor cells and the high affinity of tumors 
for folic acid provide a unique opportunity for folic acid to 
be used as a targeting ligand to deliver therapeutic agents 
to cancer cells via folate receptor-mediated endocytosis.10 
Folate-mediated targeting liposomes has been obtained by the 
incorporation of a small amount of folate-polyethyleneglycol-
distearoyl-phosphatidyl-ethanolamine.11
In this study, we explored the potential use of a novel 
conjugate, folate-poly (PEG-cyanoacrylate-co-cholesteryl 
cyanoacrylate) (FA-PEG-PCHL) for liposome targeting by 
insertion into liposomal bilayers. Docetaxel is used as a model 
hydrophobic anticancer drug, and shows high anticancer 
efficacy in patients with ovarian carcinoma, lung cancer, 
advanced breast cancer, and head/neck cancer.12 The incorpo-
ration of PEG can prolong the residence time of liposomes in 
the blood, and efficient folate receptor binding and endocyto-
sis of folate-derived liposomes can be achieved by separating 
folate from the liposomal surface when a PEG spacer is used,13 
for the reason that folic acid has the flexibility to interact with 
the corresponding cell surface   receptor.14 As a result, PEG 
was selected as the hydrophilic group to achieve a long cir-
culation effect and better connection performance from folic 
acid. Meanwhile, the hydrophobic domains are formed by the 
poly cholesteryl cyanoacrylate moieties. We modified this 
block copolymer with cholesterol in order to achieve better 
compatibility with the lecithin bilayer.15 Cholesterol is often 
used to modify biomaterials hydrophobically due to its rigid 
and highly hydrophobic sterol skeleton.16,17
The two main goals of the present work were, firstly, to 
report a novel amphiphilic copolymer, ie, FA-PEG-PCHL, 
with a series of molecular weights (4374–12394 Da) and low 
cytotoxicity, and, secondly, to investigate the characteristics, 
in vitro cytotoxicity, intracellular uptake, apoptotic effect, in 
vivo pharmacokinetics, and tissue distribution of FA-PEG-
PCHL- modified, freeze-dried docetaxel-loaded liposomes 
(FA-PDCT-L).
Materials and methods
Materials
α-Amino-ω-hydroxy-polyethyleneglycol (NH2-PEG-OH, 
molecular weights 2 kDa, 4 kDa, and 10 kDa) was purchased 
from Alfa Aesar (Heysham, UK). Dicyclohexylcarbodiimide, 
cyanoacetic acid, cholesterol, and 1, 4-(dimethylamino) pyri-
dine (DMAP) were purchased from Acros Organics   (Geel, 
Belgium). Cyanoacetic acid was dried over phosphorus 
pentoxide at 40°C for 48 hours. Docetaxel and paclitaxel 
were purchased from Ningbo Chemical Factory (Ningbo, 
China). Soybean lecithin was supplied by Shanghai Taiwei 
Pharmaceutical Industry (Shanghai, China). Docetaxel 
injection (Taxotere®) was from Aventis Pharma SA (Antony 
Cedex, France), and coumarin-6 was from Sigma-Aldrich 
(St Louis, MO). All other chemicals and solvents were of 
reagent grade and the solvents were dehydrated by molecular 
sieving.
Animals
Male Wistar rats (200 ± 20 g) and male Kunming strain mice 
(20–25 g) were from the Shenyang Pharmaceutical Univer-
sity Animal Institution. The rats were housed under standard 
conditions and were fed on a commercial diet and had access 
to water ad libitum. All animal experiments were carried out 
in accordance with the Guide for the Care and Use of Labora-
tory Animals of the National Research Council. The protocol 
was approved by the local animal ethics committee.
cell culture
For cell culture, mouse connective tissue fibroblast cells 
(L929), human breast adenocarcinoma cells (MCF-7), and 
human lung adenocarcinoma cells (A-549) were obtained 
from Nanjing Keygen Biotech Co Ltd (Nanjing, China). The 
reagents employed in this study were as follows: RPMI 1640, 
F-12k medium (Hyclone, Logan, UT), fetal bovine serum 
(Gibco, Grand Island, NY), trypsin (Sigma-Aldrich) and 
dimethyl sulfoxide (Sigma-Aldrich). All other materials were 
used without further purification. All cells were maintained in 
a medium supplemented with penicillin 10% (v/v) 100 U/mL 
and streptomycin 100 µg/mL. Cells were incubated at 37°C 
in a humidified atmosphere containing 5% CO2.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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synthesis of copolymers  
of FA-Peg-PchL
Preparation of cyanoacetate esters
The amino group of NH2-PEG-OH was protected by 
making it into t-butyloxycarbonylamino-ω-hydroxyl-
polyethyleneglycol (t-boc-NH2-PEG-OH).18 As shown in 
Figure 1A, a mixture of 20 mmol triethylamine, 18 mmol 
di-t-butyl dicarbonate, and 20 mmol NH2-PEG2000-OH in 
300 mL dichloromethane was stirred for 72 hours. HCl 0.5 
M was then added to the mixture. The organic layer was 
separated and washed with saturated NaCl solution. The 
organic phase was separated again and dried over MgSO4. 
The solvent was evaporated and the residue was allowed 
to cool under vacuum. t-boc-NH-PEG cyanoacetate was 
prepared by esterification of the cyanoacetic acid with boc-
NH-PEG-OH in dichloromethane at room temperature under 
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Figure 1 synthesis of folate-poly (Peg-cyanoacrylate-co-cholesteryl cyanoacrylate) (FA-Peg-PchL).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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nitrogen, in the presence of dicyclohexylcarbodiimide and 
DMAP as the catalyst. Cyanoacetic acid 10 mmol and boc-
NH-PEG-OH 5 mmol (molar ratio 2:1) were placed into a 
glass flask and dissolved in dichloromethane 40 mL and dicy-
clohexylcarbodiimide 11 mmol, and a catalytic amount of 
DMAP were added. After stirring for six hours, the solid was 
filtered off and washed three times with CH2Cl2 15 mL. The 
combined filtrates were concentrated under reduced pressure 
to obtain viscous oil which was solidified after 12 hours. The 
crude boc-NH-PEG cyanoacetate obtained was used directly 
in the polymerization step without further purification. The 
cyanoacetate ester of cholesterol was prepared according to 
the same procedure as aforementioned (Figure 1A).
condensation/polymerization
The reaction scheme for condensation of t-boc-NH2-PEG 
cyanoacetate with cholesteryl cyanoacetate in the presence 
of formalin and dimethylamine, as previously described 
was shown in Figure 1B. Briefly, t-boc-NH2-PEG cyano-
acetate 1 mmol and cholesteryl cyanoacetate 5 mmol were 
dissolved in ethanol/dichloromethane 20 mL (1:1, v/v) in a 
glass flask, and formalin 10 mmol (37%, w/v) and dimeth-
ylamine 10 mmol (40%, w/v) were added.18 The reaction 
was carried out at room temperature under nitrogen. After 
stirring for 12 hours, the reaction mixture was poured into 
water and extracted with dichloromethane. The combined 
organic phases were dried over MgSO4. The solvent was 
evaporated, and the residue was placed several hours under 
vacuum to cool down.
The amino group of t-boc-NH2-PEG was deprotected by 
trifluoroacetic acid in dichloromethane (Figure 1B).19 Briefly, 
trifluoroacetic acid 1 mL was added to polymer 1 mmol solu-
tion, and the reaction was carried out for one hour at room 
temperature under magnetic stirring. The reaction mixture 
was then neutralized with 10% aqueous sodium bicarbonate 
solution and extracted with dichloromethane. The organic 
layer was dried over MgSO4 and evaporated under reduced 
pressure to give a pale yellow waxy material.
conjugation of folic acid and Nh2-Peg-PchL
Folate-conjugated co-copolymer was synthesized by coupling 
the NH2-PEG-PCHL to an activated folic acid as described 
in the previous studies with a minor modification.11,20,21 As 
shown in Figure 1C, NH2-PEG-PCHL 1 mmol dissolved in 
dimethyl sulfoxide 30 mL was mixed with folic acid 4 mmol 
and dicyclohexylcarbodiimide 1.2 mmol, and two drops of 
triethylamine was then added as a catalyst. The reaction 
was performed at room temperature for 12 hours, and the 
reaction solution was then filtered. The filtrate was dialyzed 
in dimethyl sulfoxide for 72 hours to remove free folic acid 
and then dialyzed for another 72 hours to eliminate dimethyl 
sulfoxide. The mixture was freeze-dried in a dialysis bag to 
give the final product.
characterization of polymers
FTIr spectra, 1h-NMr spectra and MW of polymers
Fourier transform infrared (FTIR) spectra were obtained 
from a neat film cast from the dimethyl sulfoxide copoly-
mer solution between KBr tablets on an FTIR spectrometer 
(IFS-55, Bruker Corporation, Switzerland). 1H-NMR spectra 
was recorded in deuterated pyridine for PEG-PCHL and 
in deuterated dimethyl sulfoxide for FA-PEG-PCHL by 
1H-NMR spectroscopy (ARX-300, Bruker Corporation, 
Fällanden, Switzerland). Gel permeation chromatography 
of PEG-PCHL was performed in tetrahydrofuran (Fisher 
Scientific, Fair Lawn, NJ) of high-pressure liquid chromato-
graphy grade with a Waters Alliance 2690 separation module 
(Waters Corporation, Milford, MA) equipped with a set of 
two Waters Styragel columns having pore size diameters of 
103 and 100Å, and a Waters 2410 refractive index detec-
tor (Waters Corporation). A series of narrow polystyrene 
  (Polymer Laboratories, Amherst, MA) molecular weight 
standards (30–500 kDa) were used to calibrate the gel per-
meation chromatography system.
cytotoxicity of polymers by ccK-8 assay
The L929 cell line was selected to evaluate cytotoxicity as a 
direct contact test, as recommended by USP 26. The experi-
ment was carried out according to the method described for 
the Cell-Counting Kit 8 (Fluka, St Louis, MO).22 The copoly-
mers were added as free solutions. The relative cell viability 
compared with control cells containing cell culture medium 
without polymer was calculated as [A]test/[A]control.
Liposome preparation
Liposomes were prepared using an organic solvent injection 
method.23 Briefly, in all formulations containing polymers 
of different molecular weight, a mixture of FA-PEG-
PCHL 0.005 mmol, docetaxel 0.012 mmol, and soybean 
lecithin 0.25 mmol was dissolved in tetrahydrofuran 5 mL. 
The solution was injected into purified water at 25°C and 
the suspension obtained was stirred for 180 minutes to 
facilitate the removal of tetrahydrofuran. To obtain a uniform 
particle size distribution, the suspension was sonicated at a 
frequency of 20–25 kHz and power of 500 W for 2.5 minutes 
by a probe-type sonicator (JY92-II, Scientz, Ningbo, China) International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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and then sterilized by filtering through a 0.22 µm cellulose 
acetate filter. Appropriate amounts of cryoprotectants 
(5%, w/v) were dissolved in the liposome dispersion. The 
samples were frozen at −85°C for eight hours before being 
lyophilized using a freeze drier (Eyela FDU-1100, Prkakikai, 
Tokyo, Japan). The drying time was 36 hours. The resulting 
solid matrix was collected for later experiments after rehydra-
tion with deionized water.
characterization of liposomes
Transmission electron microscopy
FA-PDCT-L were viewed before and after lyophilization 
under an electron microscope (JEM-1200 EX, JEOL, Tokyo, 
Japan) by conventional negative staining methods using phos-
photungstic acid buffer 0.3% (pH 6.0) as a staining agent.23
Particle size distribution, zeta potentials,  
and fixed aqueous layer thickness
Particle size distribution and zeta potentials for FA-PDCT-L 
were determined by dynamic light scattering and electro-
phoretic light scattering, respectively, both using ELS 800 
apparatus (Otsuka Electronics, Osaka, Japan) at 25°C after 
dilution of the dispersion to an appropriate volume with 
Millipore-filtered water. According to the Gouy-Chapmann 
theory, the zeta potentials of samples diluted with NaCl solu-
tions at a series of concentrations (0 M, 0.01 M, 0.05 M, and 
0.1 M) measured and plotted against the slope L gives the 
position of the slipping plane or fixed aqueous layer thickness 
FALT) in nm units. FALT was calculated by:
  lnψ (L) = lnA-κL
where ψ (L) is the electrostatic potential at the position of 
the slipping plane L (nm), A is the constant, and κ is the 
  Debye-Huckel parameter which equals C−2/0.3 for univalent 
salts, where C is the molality of electrolytes.24
Determination of entrapment efficiency
The liposome entrapment efficiency was determined using 
an ultrafiltration technique for separating the nonentrapped 
drug from liposomes.25 Briefly, 5 mL of drug-loaded 
liposomes were placed in a stirred cell (Millipore 8010, 
Millipore Corporation, Bedford, MA) fitted with a filter 
membrane (molecular weight cutoff 50,000) under nitrogen. 
The ultrafiltrate was collected, and the drug content in the 
ultrafiltrate (Cfree) was determined by high-pressure liquid 
chromatography using an LC-ATvp pump and SPD-10 Avp 
ultraviolet light detector (Shimadzu, Kyoto, Japan) and a 
Diamonsil C18 analytical column 250 mm × 4.6 mm, 5 µm 
(Dikma, Tianjin, China).26 The injection volume was 20 µL 
and docetaxel was detected at 228 nm. The mobile phase 
consisted of acetonitrile and water (53:47, v/v) delivered at 
a flow rate of 1.0 mL/minute. A liposomal suspension 1 mL 
was then diluted with absolute ethanol to determine the total 
docetaxel (Ctotal) by high-pressure liquid chromatography. 
The entrapment efficiency (EE%) was calculated as:
 
EE% =
−
×
cc
c
totalf ree
total
100   (1)
In vitro drug release
The drug release profile for the docetaxel-loaded liposomes 
was studied using a dialysis method in vitro. Briefly, an 
aliquot of FA-PDCT-L were diluted 50-fold with phosphate 
buffer (0.1 M, pH 7.4) containing Tween 80 (0.3%, w/v), 
thereby improving the solubility of docetaxel in phosphate-
buffered saline, and incubated in buffer at 37°C under 
magnetic stirring in a dialysis bag (molecular weight cutoff 
7000 Da). Aliquots of 1 mL were withdrawn from the release 
medium and replaced by an equal volume at each sampling 
time. The amount of docetaxel was determined by high-
pressure liquid chromatography. All operations were carried 
out in triplicate.
cytotoxicity of liposomes
A CCK-8 assay was performed to compare the cytotoxic 
effects of docetaxel solution, FA-PDCT-L, and empty FA-
PEG-PCHL-modified liposomes (FA-P-L) against two 
cancer cell lines in vitro using a previously established   
method.27–29 Before the experiment, MCF-7 breast cancer 
cells and A-549 lung cancer cells were precultured until con-
fluence was reached. After incubating the cells in   docetaxel 
solution, FA-PDCT-L, and FA-P-L for 24, 48, and 72 hours, 
with docetaxel concentrations ranging from 0.5 nM to 40 nM, 
the CCK-8 assay was performed and the percentage cell 
viability was determined. Error bars were obtained from 
triplicate samples.
In vitro cellular uptake of liposomes
Confocal laser scanning microscopy was used to visu-
alize the interaction of the colloidal particles with the 
cancer cells. For fluorescence imaging of cellular uptake, 
MCF-7 cells at a density of 1 × 106 cells/mL were culti-
vated for 24 hours on coverslips in six-well culture plates 
(1 mL/well).   Coumarin-6 solution was prepared following the 
same prescription and preparation process as for Taxotere. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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  Suspensions of coumarin-6-loaded liposomes (COU-L) and 
coumarin-6-loaded FA-PEG4000-PCHL-modified liposomes 
(FA-PCOU4000-L) were then added (200 µL/well) to the cell 
culture medium at a concentration of 100 µg/mL. Cells were 
washed three times after incubation for two hours and then 
fixed using 4% (v/v) paraformaldehyde aqueous solution. 
After 10 minutes of fixing at room temperature, followed 
by rinsing with phosphate-buffered saline, propidium iodide 
10 µg/mL in phosphate-buffered saline was added to stain the 
nuclei for 30 minutes. The stained cells were then washed 
with phosphate-buffered saline and observed using a confo-
cal laser scanning microscopy system (TCS SP2/AOBS, 
Leica, Germany).
Acridine orange/ethidium  
bromide staining
Morphological demonstration of apoptosis was done using 
acridine orange/ethidium bromide staining. MCF-7 cells 
were cultured and divided into control and test groups. 
Normal cells were treated with serum-free medium for 
24 hours. Test groups were treated with docetaxel solution, 
docetaxel-loaded liposomes, and FA-PDCT-L, respectively, 
for 24 hours at a docetaxel concentration of 20 µg/mL. 
After removal of the incubation medium, MCF-7 cells were 
harvested with trypsin 0.25% solution and treated with dye 
mixture (a normal/apoptotic/necrotic cell detection kit, Nan-
jing KeyGen Biotech Co Ltd, China). Double-staining using 
these two agents provided the percentage of live, apoptotic, 
and necrotic cells. The cells were observed immediately 
using an Olympus B × 61 fluorescence microscope (Tokyo, 
Japan) and the appropriate fluorescein filter. Acridine orange 
exhibits green fluorescence and ethidium bromide exhibits 
red fluorescence when bound to DNA. In this way, it is pos-
sible to distinguish between viable (green fluorescence with 
intact nucleus), early apoptotic (green fluorescence with 
chromatin condensation), late apoptotic (orange fluorescence 
with chromatin condensation), and necrotic cells (orange 
fluorescence with intact nucleus).
Annexin V/propidium iodide  
double staining
MCF-7 cells were divided and treated as aforementioned, 
then detached by trypsin and washed twice. Apoptotic cells 
were identified by binding of fluorescein-labeled annexin V 
to exposed phosphatidylserine on the cell surface and necro-
sis by nuclear staining with propidium iodide. Cell clusters 
were identified as described in the annexin V-FITC staining 
kit (Nanjing KeyGen Biotech Co Ltd, China) according to 
the manufacturer’s recommendations with flow cytometric 
analysis (FACSCalibur, BD Biosciences, San Jose, CA), and 
a dot plot of FL1 (annexin V) and FL2 (propidium iodide) 
was constructed to show the gated events. Quadrant markers 
were applied to identify the four cell populations (annexin V−/
propidium iodide+, annexin V+/propidium iodide+, annexin 
V−/propidium iodide−, annexin V+/propidium iodide−). The 
results were expressed as a percentage of the gated events.9
Pharmacokinetics
Twelve male Wistar rats were fasted overnight and randomly 
divided into two groups of six rats each for an in vivo phar-
macokinetics study. A docetaxel solution as a reference and 
FA-PDCT-L were injected intravenously at a dose of 10 mg/kg. 
Blood samples were collected from the orbital plexus at pre-
determined time points into heparinized tubes and then centri-
fuged at 5000 rpm for five minutes to separate the plasma.
To analyze the plasma samples, paclitaxel (20 µL of a 
methanol 10 µg/mL solution) was added as the internal stan-
dard to 200 µL of plasma and the mixture was extracted with 
ether before being centrifuged. Docetaxel in the supernatant 
was dried under nitrogen and redissolved in methanol for 
liquid chromatography-mass spectrometry measurement. 
The assay was performed on a liquid chromatography-mass 
spectrometry system (2010A, Shimadzu). Liquid chromato-
graphic separation was achieved on a Kromasil C18 column 
(150 mm × 4.6 mm, 5 µm) and preceded by a C18 guard 
column (4.0 mm × 2.0 mm, Phenomenex, Torrance, CA). 
The column and autosampler tray temperatures were kept 
constant at 25°C and 4°C, respectively. The mobile phase 
was methanol and water (75:25, v/v). The flow rate was set at 
0.8 mL/min, with 25% of the eluent splitted into the inlet of 
the mass spectrometer. The injection volume was 10 µL.
The analytes were ionized by an ESI source in positive 
ion mode under the following source conditions: nebulizing 
gas 1.5 L/min; drying gas 2.0 L/min; curved desolvation line 
temperature 250°C; heat block temperature 200°C; detector 
voltage 1.70 kV; and other parameters fixed as for the tun-
ing file. Analysis was carried out by selected ion monitoring 
at [M + Na]+ m/z 830.50 for docetaxel and at [M+Na]+ m/z 
876.50 for paclitaxel. The internal standard ratio was cal-
culated for each standard by dividing the analyte peak area 
by the peak area of the internal standard. Standard curves 
of docetaxel and paclitaxel were constructed by plotting the 
internal standard ratio versus the concentration of analyte 
in each sample. Standard curves were fit by linear regres-
sion with weighting by 1/y2, followed by back calculation 
of concentrations.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Tissue distribution of liposomes  
in sarcoma-180 solid tumor-bearing mice
Male Kunming mice, body weight 20–25 g, were used 
for biodistribution studies after sarcoma-180 cells were 
implanted intradermally into the armpit for one week. 
Twenty-seven tumor-bearing mice were fasted overnight 
and randomly divided into three groups of nine mice each. 
Docetaxel solution, docetaxel-loaded liposomes for refer-
ence, and reconstituted freeze-dried FA-PEG4000-PCHL-
modified docetaxel liposomes (FA-PDCT4000-L) were 
injected intravenously at a dose of 20 mg/kg. Another three 
animals were sacrificed without treatment, and their tissues 
were used as blank controls and for preparation of spiked 
control samples.
The animals were decapitated in groups of three at seven, 
120, and 240 minutes, and the heart, liver, spleen, lungs, 
kidneys, brain, and tumor tissue were removed, washed of 
residual blood, air-dried, and weighed. Tissue samples were 
homogenized with saline 0.2 mg/mL, and methanol solution 
20 µL containing paclitaxel 10 µg/mL was then added as the 
internal standard. Tissue samples were extracted with ether 
and then centrifuged. The supernatants were dried under 
nitrogen and redissolved in methanol for liquid chromatogra-
phy-mass spectrometry measurement as described earlier.
statistical analysis
Statistical analysis of the cytotoxicity of FA-PEG2000-
PCHL, FA-PEG4000-PCHL, and FA-PEG10000-PCHL, 
and the effects of the three polymers on particle size, zeta 
potentials, FALT, entrapment efficiency, and mean 24-hour 
cumulative release (%) of the various formulations were 
performed using the Kruskal–Wallis test. In all cases, post 
hoc comparisons of the means of individual groups were 
performed using the least significant difference test.
Plasma drug concentration-time data for docetaxel in indi-
vidual rats were analyzed by noncompartmental estimations 
using 3p87 software (Chinese Society of Mathematical Phar-
macology, Beijing, China). Plasma and tissue concentrations 
of docetaxel obtained from the rats were pooled to provide 
mean concentrations. Statistical analysis of the pharmacoki-
netic parameters (peak concentration [Cmax], clearance, mean 
residence time from time 0 extrapolated to infinity [MRT] and 
area under the plasma-concentration time curve from time 
0 extrapolated to infinity [AUC]) for the docetaxel solution, 
docetaxel-loaded liposomes, and   FA-PDCT4000-L were 
carried out using the one-way analysis of variance t-test. 
Differences in tissue drug concentrations at different time 
points were estimated using the Kruskal–Wallis test, and 
post hoc comparisons of the means of individual groups 
were performed using the least significant difference test. 
A significance level of P , 0.05 denoted significance in all 
cases. Statistical analysis was performed using SPSS ver-
sion 17.0 (SPSS Inc, Chicago, IL). Each experiment was 
conducted three times to ascertain reproducibility.
Results and discussion
characterization of polymers
FTIr spectra
The FTIR spectrum of NH2-PEG-PCHL (Figure 2A) showed 
absorption bands related to the CN stretching vibration at 
2177.6 cm−1 and the ester carbonyl at 1741.6 cm−1. The 
C−O stretching of PEG appeared at 1112.0 cm−1. The FTIR 
spectrum of FA-PEG-PCHL (Figure 2B) showed absorption 
bands related to CN stretching vibration at 2244.0 cm−1 and 
the ester carbonyl at 1741.8 cm−1. The C−O stretching of PEG 
appeared at 1108.9 cm−1. The C=C and =C−H stretching 
vibration of aromatic ring of folate showed at 1536.9 and 
842.5 cm−1, respectively.
1h-NMr spectra
The  1H-NMR spectra were consistent with the structure 
of the expected polymers. Figure 3 shows the spectrum of 
  PEG-PCHL. The peaks at 3.70–4.20 ppm were attributed 
to the methylene in the R-position of the ester groups. The 
signal at 2.20–2.80 ppm and the resonance at 3.62 ppm were 
assigned to the methylene protons of poly(cyanoacrylate) and 
the PEG backbone, respectively. Signals at 0.84–2.20 ppm 
were assigned to the methylene and methyl protons of the cho-
lesteryl skeleton. The peak at 0.66 ppm was attributed to the 
methyl protons of the cholesteryl side chain. Figure 4 shows 
the spectrum of FA-PEG-PCHL. The peaks at 3.70–4.20 ppm 
were attributed to the methylene in the R-position of the 
ester groups. The resonance at 3.51 ppm was assigned to 
the methylene protons of the PEG backbone. The signal at 
2.00–2.40 ppm and the resonance at 4.50 ppm were attributed 
to the methylene in the R-position for the amide groups of 
folate, respectively. The signals at 6.61 ppm, 7.41 ppm, and 
the resonance at 8.66 ppm were attributed to the protons of 
the aromatic ring of folate, separately. Signals at 0.80–2.00 
ppm were assigned to the methylene and methyl protons of 
the cholesteryl skeleton. The peak at 0.65 ppm was attributed 
to the methyl protons of the cholesteryl side chain.
Molecular weights
The molecular weights of the obtained polymers, as well as 
the polydispersity indices, were calculated by gel permeation International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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chromatography. Table 1 reports the data for polymers with 
different chain lengths of PEG. A low molecular weight and 
low polydispersity index were achieved. The unimodal mass 
distribution excluded the presence of poly-(PEG acrylate) or 
poly-(cholesteryl acrylate). Because the condensation of alkyl 
cyanoacetates with formaldehyde is a method described for 
the synthesis of alkyl cyanoacrylate monomers, the   formation 
of a poly-(alkyl cyanoacrylate) with a low molecular weight 
was expected.18 Furthermore, the interest in using poly-(alkyl-
cyanoacrylate) in controlled drug delivery is due to its rapid 
degradability by erosion after hydrolysis of the lateral ester 
chain and the formation of water-soluble poly-(cyanoacrylic 
acid), which is eliminated by renal excretion.30 Thus, a low 
molecular weight is an important issue for the degradability 
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Figure 3 1h-NMr spectrum of Peg-PchL.
properties of the obtained material. Finally, the molecular 
weight of the “hydrophobic” alkyl cyanoacrylate part of the 
copolymer was of the same order as that observed in nano-
particles prepared by emulsion/butyl cyanoacrylate, well- 
known to degrade rapidly in vivo.31
cytotoxicity by ccK-8 assay
The relative cell viability compared with control cells 
containing cell culture medium without polymer was calcu-
lated by [A]test/[A]control. Based on the viability of L929 cells 
incubated together with various polymers, FA-PEG-PCHL 
showed no cytotoxicity with experimental concentrations 
up to 1500 µg/mL in cell culture (Figure 5). No significant 
difference was found between the groups (P . 0.05).
characterization of liposomes
Investigation of cryoprotectants
Liposomal lyophilization is one of the most promising 
procedures for keeping liposomes stable during long-term 
storage.32 Therefore, different cryoprotectants, ie, lactose, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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dextran, sucrose, trehalose, and mannitol (%, w/v), were 
evaluated as candidates after preliminary experiments 
according to the appearance, morphology, and stability of 
the lyophilized liposomes after reconstitution.
In terms of the protective effect of lyoprotectants (lactose, 
sucrose, trehalose, and dextran), the size and encapsulation 
efficiency of FA-PDCT-L before and after lyophilization 
were similar (data not shown). In particular, the dried product 
obtained with trehalose was satisfactory in appearance and 
was easy to reconstitute, with an unchanged and uniform 
size distribution. As far as mannitol was concerned, the 
lyophilized product had a smooth and bright appearance, 
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Table 1 MWs and polydispersity index of polymers
MW Polydispersity index
Peg2000-PchL   4374 ± 91 1.3
Peg4000-PchL   6388 ± 115 1.4
Peg10000-PchL 12394 ± 415 1.7
Note: Values are mean ± sD (n = 3).
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Figure 5 cytotoxicity of FA-PDcT2000-L, FA-PDcT4000-L, and FA-PDcT10000-L in L929 (n = 3). The polymers were added as free solutions.
but was difficult to rehydrate, together with a significant 
increase in particle size. Therefore, we chose trehalose as 
the lyoprotectant (5%, w/v).
Morphology analysis
The morphological images of FA-PDCT-L before and after 
lyophilization are shown in Figure 6. In all cases, spherical 
or ellipsoid-shaped particles were found.
PSD, zeta potentials, FALT, and entrapment efficiency
A unimodal particle size distribution was observed, and FA-
PDCT-L with polymers of different molecular weight had 
a similar particle size distribution, ranging from 111 nm to 
127 nm, as shown in Table 2. Meanwhile, the negativity of 
the zeta potential for the liposomes decreased dramatically 
with increasing PEG chain length (P , 0.05). Increasing 
NaCl concentration also led to reduction of the negative 
surface charge of the liposomes, indicating that the FALT 
of the liposomes increased dramatically with length of the 
PEG chain (P , 0.05). The data suggested that the surface 
structure of FA-PDCT-L fitted a “mushroom” structure, with 
FALT no more than 10 nm.33 “Mushroom” structure theory 
postulates that PEG, folding on the surface of the liposomes 
due to its compressibility, is favorable for liposomes to 
prevent aggregation and improve its ability to evade uptake 
by macrophages. The entrapment efficiency of liposomes 
with or without modification was not significantly different, 
indicating that the loading of polymers did not change the 
encapsulation ability of the liposomes.
In vitro release
There was no obvious burst release of drug for up to 24 hours, 
and a prolonged release phenomenon was showed in all groups 
(Figure 7). The release rate was faster with higher molecular 
weights of the polymer, showing a molecular-  dependent 
release profile. The cumulative amount of docetaxel released 
within 24 hours was 40.8% for docetaxel-loaded liposomes, 
while a significant decreased amount of docetaxel in FA-
PDCT-L was released over 24 hours, ie, 19.5%, 27.2%, and 
31.1% for FA-PDCT2000-L, FA-PDCT4000-L, and FA-
PDCT10000-L, respectively (P , 0.05). Polymer-modified 
liposomes released drug significantly more slowly than 
nonmodified liposomes because of the poly   (cholesteryl International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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A
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200 nm
200 nm
Figure 6 Transmission electron microscopy images of FA-PDcT-L before (A) and 
after (B) lyophilization.
cyanoacrylate) moieties in the polymer. Cholesterol is known 
to enhance the rigidity of the lethicin bilayer.34 As a result, 
incorporation of the polymer possibly altered the flexibil-
ity of the liposomal bilayer, and reduced the rate of drug 
release. We also observed that the mass of the hydrophilic 
group of the polymer significantly influenced the rate of 
drug release. The higher the chain length of PEG, the faster 
the rate of drug release, and this may be attributable to the 
loose structure of FA-PDCT10000-L, leading to   accelerating 
drug release.
cytotoxicity of liposomes
The in vitro cytotoxic activity of docetaxel solution, docetaxel-
loaded liposomes, and FA-PDCT-L is shown in Table 3. 
The IC50 of FA-PDCT2000-L, FA-PDCT4000-L, and FA-
PDCT10000-L was significantly lower than that of docetaxel 
solution and docetaxel-loaded liposomes in both cancer cell 
lines for all incubation time periods. FA-PDCT4000-L showed 
significant advantages in inhibiting cancer cell proliferation 
when compared with the docetaxel solution and docetaxel-
loaded liposomes. In comparison with docetaxel solution, the 
IC50 for FA-PDCT4000-L decreased to 83.6%, 71.1%, and 
58.4% in the MCF-7 line, and to 76.3%, 65.3%, and 66.3% in 
the A-549 line after 24, 48, and 72 hours of treatment, respec-
tively, while in comparison with docetaxel-loaded liposomes, 
the IC50 for FA-PDCT4000-L decreased to 82.6%, 75.9%, and 
65. 5% in the MCF-7 line and to 74.6%, 75.9%, and 67.8% 
in the A-549 line after 24, 48, and 72 hours of treatment, 
respectively, showing a significant reduction in IC50 values. 
Compared with FA-PDCT2000-L and FA-PDCT4000-L, the 
IC50 of FA-PDCT10000-L was significantly higher in both cell 
lines. FA-P-L demonstrated no significant cytotoxic effect in 
either the MCF-7 line or in the A-549 line, even at concen-
trations as high as 1000 µg/mL (data not shown). IC50 values 
could not be determined accurately for FA-P-L.
In vitro cytotoxicity studies showed that FA-PDCT-L 
was significantly more cytotoxic in MCF-7 and A-529 lines 
compared with the docetaxel solution and docetaxel-loaded 
liposomes (Table 3). Higher dose and longer duration of 
exposure led to an improved effect. Thus, a lower amount 
of docetaxel associated with liposomes will be required to 
achieve the same effect as docetaxel solution alone, which 
is anticipated to reduce the side effects of docetaxel. The 
greater antiproliferative effect was attributed mainly to a 
higher intracellular drug level as a result of folate-mediated 
phagocytosis or reduced exocytosis involving a xenobiotic 
extrusion pump, or both.35,36 The IC50 of FA-PDCT10000-L 
was significantly higher than that of FA-PDCT2000-L and 
FA-PDCT4000-L, which could be explained by overfolding 
Table 2 characteristics of FA-PDcT-L and FA-PcOU-L
Liposome type Mean particle size  
(nm)
Polydispersity  
index
EE (%) Zeta potential  
(mv)
FALT  
(nm)
DcT-L 123.7 ± 12.8 0.19 ± 0.04 97.6 ± 1.4 −32.15 ± 1.5 0.40 ± 0.05
FA-PDcT2000-L 126.9 ± 10.2 0.20 ± 0.03 97.7 ± 1.1 −14.13 ± 0.8* 3.48 ± 0.03*
FA-PDcT4000-L 111.6 ± 9.6 0.17 ± 0.04 97.8 ± 1.6 −11.87 ± 2.1* 3.97 ± 0.09*
FA-PDcT10000-L 119.7 ± 11.4 0.18 ± 0.05 97.6 ± 1.3  − 6.54 ± 1.0* 5.61 ± 0.07*
cOU-L 118 ± 10.5 0.18 ± 0.03 99.9 ± 0.8 −34.51 ± 2.1 0.43 ± 0.06
FA-PcOU4000-L 113 ± 9.1 0.16 ± 0.04 99.8 ± 0.7 −10.62 ± 1.8 4.10 ± 0.08
Note: Values are mean ± sD (n = 3). *P , 0.05 vs DcT-L.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 7 Release profiles of DCT from liposomes in vitro. 
Note: Values are mean ± sD (n = 3). *P , 0.05 vs DcT-L.
of the PEG10000 chain blocking folate, which is the key to 
mediation of phagocytosis for PEGylated liposomes.
In vitro cellular uptake of liposomes
To investigate folate-mediated cellular uptake, a short-term 
particle endocytosis test was carried out visually using 
coumarin-6 solution, COU-L, and FA-PCOU4000-L. To 
have a reliable means of comparison, the physiochemical 
characteristics of COU-L are shown in Table 2, and there 
was no significant difference between the drug-loaded lipo-
somes and COU-L (P . 0.05). Figure 8 shows that COU-L 
(green fluorescent dots) penetrated the cells and was mostly 
distributed in the cytoplasm around the nucleus. Furthermore, 
the green fluorescent dots in samples incubated with FA-
PCOU4000-L were more concentrated than those incubated 
with coumarin-6 solution and COU-L. These images demon-
strate the improved effect of folate on cellular uptake, which 
could be a possible explanation for the higher cytotoxicity 
of the FA-PEG-PCHL-modified liposomes.
Acridine orange/ethidium bromide 
staining
To investigate the enhanced effect of FA-PEG-PCHL on 
induction of apoptosis by the docetaxel-loaded liposomes, 
MCF-7 cells were stained after treatment with acridine orange/
ethidium bromide, which combines the differential uptake of 
fluorescent DNA binding dyes, acridine orange, and ethidium 
bromide, allowing distinction between viable, apoptotic, and 
necrotic cells. Figure 9 shows late apoptotic cells (yellow 
stain) and necrotic cells (red stain) when exposed to docetaxel 
solution, docetaxel-loaded liposomes, and FA-PDCT4000-L. 
When treated with FA-PDCT4000-L, the number of apoptotic 
and necrotic cells was significantly increased, which con-
firmed the results for cytotoxicity of the liposomes.
Annexin V/propidium iodide  
double staining
Flow cytometric analysis with annexin V and propidium 
iodide staining was performed to detect apoptosis by targeting 
the loss of phospholipid asymmetry in the plasma membrane. 
MCF-7 cells were analyzed by flow cytometry after staining 
of phosphatidylserine translocation with FITC-annexin V in 
combination with propidium iodide. Phosphatidylserine is a 
lipid found on the inner surface of the cell membrane. When 
undergoing apoptosis, cells externalize phosphatidylserine, 
which can then be labeled with fluorochrome-conjugated 
annexin V . The MCF-7 cells were divided into four groups, 
ie, mechanically injured cells (left upper part, annexin International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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A
Column 1 Column 2 Column 3
B
C
Figure 8 confocal laser scanning microscopy images showing the internalization of 
fluorescent preparations in MCF-7 cells (2 h incubation). Column 1: FITC channels 
showing green fluorescence from coumarin-6-loaded preparations distributed in the 
cytoplasm. Column 2: PI channels showing red fluorescence from propidium iodide-
stained nuclei. column 3: Merged channels of FITc and PI. rows A: coumarin-6 
solution. rows B: cOU-L. row c: FA-PcOU4000-L.
AB
CD
Figure 9 Morphological detections of McF-7 in different groups by AO/eB double 
staining. (A) control group, (B) DcT solution, (C) DcT-L, (D) FA-PDcT4000-L.
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V−/propidium iodide+), healthy living cells (left lower part, 
annexin V−/propidium iodide−), cells at the stage of early 
apoptosis (right lower part, annexin V+/propidium iodide−), 
and necrotic cells or cells exhibiting late-stage apoptosis 
(right upper part, annexin V+/propidium iodide+). The cells 
within each cluster were then counted and represented as a 
percentage of the gated cells. Cells of both the right upper 
and right lower parts were considered to be apoptotic. There 
was a significant difference among the experimental groups. 
Figure 10 indicates that the percentage of early apoptotic International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 10 Dual parameter flow cytometry analysis of MCF-7 cells with annexin V/PI staining. A) control group, B) DcT solution, C) DcT-L, D) FA-PDcT4000-L.
cells and late apoptosis cells in the control group were 2.29% 
and 2.58%, while that of the FA-PDCT4000-L group were 
5.60% and 23.09%, which were significantly higher than for 
both the docetaxel solution group (3.91% and 11.46%) and 
the docetaxel-loaded liposomes group (4.50% and 12.01%), 
thus showing a significant increase in apoptosis.
Pharmacokinetics
The results of the characterization analysis and in vitro cyto-
toxicity assays for the docetaxel preparations suggest that 
FA-PDCT4000-L has a better potential for tumor targeting. 
The research reported by Gref et al also suggest that a PEG 
chain with a molecular weight around 5000 Da possesses a 
better and longer circulation effect, and that a PEG content in 
the nanoparticles above 5% (w/w) could build a good steric 
barrier for optimal protein resistance.37 Our work is consistent 
with this report. Therefore, we focused on FA-PDCT4000-L 
for a pharmacokinetic and tissue distribution study.
The plasma concentration-time curves for the docetaxel 
preparations after intravenous administration are shown in 
  Figure 11, and the pharmacokinetic parameters are listed in 
Table 4. The pharmacokinetic profiles for docetaxel showed sig-
nificant differences for FA-PDCT4000-L-modified liposomes 
versus docetaxel-loaded liposomes and docetaxel solution. In 
the docetaxel solution group, disappearance of docetaxel from 
the blood circulation was very rapid, with plasma concentra-
tions of only 63 ng/mL at six hours. In contrast, docetaxel in the 
polymer-modified liposomes was still present in the circulation 
at 12 hours. Encapsulation of docetaxel into liposomes leads 
to a significant change in pharmacokinetic parameters. In vitro 
drug-release studies indicate that docetaxel is released slowly 
from the liposomes for at least 24 hours, whereas free docetaxel 
is not readily distributed, which explains the higher initial 
plasma drug concentrations for docetaxel-loaded liposomes 
and FA-PDCT4000-L than those for docetaxel solution. As 
shown in Table 4, the AUC for FA-PDCT4000-L increased International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 11 Plasma concentrations of DcT in three preparations after intravenous administration to rats at a dose of 10 mg/kg. Values are means ± sD (n = 6).
Table 4 Pharmacokinetic parameters of DcT in three preparations after intravenous administration to rats at a dose of 10 mg/kg
DCT solution DCT-L FA-PDCT4000-L
AUc (µg ⋅ mL−1⋅min−1) 576.89 ± 37.71 940.07 ± 101.47* 3593.55 ± 185.89*,§
cmax (µg ⋅ mL−1) 25.49 ± 1.66 33.22 ± 3.55* 85.18 ± 4.39*,§
clearance (mL ⋅ min−1) 3.48 ± 0.23 2.14 ± 0.24* 0.56 ± 0.03*,§
MrT (min) 60.95 ± 0.44 80.09 ± 0.32* 199.48 ± 0.21*,§
Note: Values are means ± sD (n = 6). *P , 0.05 vs DcT solution; §P , 0.05 vs DcT-L.
6.2-fold and 3.8-fold, while the mean residence time increased 
3.3-fold and 2.5-fold compared with the docetaxel solution and 
docetaxel-loaded liposomes, respectively, with a corresponding 
decrease in clearance. This effect might be attributed to two 
factors. First, the negative zeta potential is key to the recognition 
of nanoparticles by macrophages in the mononuclear phagocyte 
system.   Therefore, a less negative or even neutral zeta potential 
is expected to be necessary to avoid the macrophage system. As 
shown in Table 2, the reduction of negative zeta potential could 
be observed in FA-PDCT4000-L in contrast with the docetaxel-
loaded liposomes. Second, FALT is an important factor for 
improving liposome stability and preventing opsonization and 
macrophage uptake. The FALT of the FA-PDCT4000-L was 
thicker than that of docetaxel-loaded liposomes.
Tissue distribution in sarcoma-180 solid 
tumor-bearing mice
Sarcoma-180 solid tumor-bearing mice were selected as the 
animal model for our biodistribution study. The   distribution 
profiles for docetaxel solution and liposomes in S180 
  tumor-bearing mice at seven, 120, and 240 minutes after 
intravenous administration are shown in Figure 12. The 
drug levels in tumor for FA-PDCT4000-L were significantly 
higher than for the other preparations at seven minutes after 
administration, and were approximately 0.6-fold and 3.1-fold 
greater than that for docetaxel solution and docetaxel-loaded 
liposomes, respectively. At 120 and 240 minutes after dosing, 
the docetaxel concentration from FA-PDCT4000-L in tumor 
remained higher in comparison with the other preparations 
and tissues. In addition, at 120 and 240 minutes after dosing, 
the tissue distribution of FA-PDCT-L was, in ranked order: 
tumor . kidney . lung . spleen . liver . heart and brain 
(P , 0.05). There were no significant differences in docetaxel 
concentrations for the three formulations in brain and heart 
tissues at any time point (P . 0.05). The higher concentration 
of docetaxel found in kidney tumor cells in FA-PDCT4000-L-
treated mice could be explained by the folate receptor effect. 
Folate receptor levels are naturally rich in the kidney and are 
overexpressed in tumor tissues.38 The clearance behavior and 
tissue distribution of intravenously injected particulate drug International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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carriers are greatly influenced by their size, surface features, 
and opsonization. Opsonins are adsorbed on the nanoparticle 
surface and promote particle recognition by the reticuloen-
dothelial system.39,40 Lipid emulsions are rapidly taken up by 
the reticuloendothelial system in the liver and spleen after 
intravenous administration.41 The presence of a long hydro-
philic chain in PEG around the shell of FA-PDCT4000-L 
would lead to a longer retention time in the circulation. As 
a result, the docetaxel concentration in liver and spleen tis-
sue in the FA-PDCT4000-L-treated group was significantly 
lower than that for docetaxel-loaded liposomes. Rich blood 
flow with high capillary permeability could be the reason for 
the accumulation in lungs. The uptake of modified liposomes 
by the brain was not improved because of lack of the folate 
receptor in the inner side walls of brain capillaries.42
Conclusion
A novel polymer, ie, (FA-PEG-PCHL), with a low molecu-
lar weight and polydispersity index was successfully syn-
thesized and used to modify docetaxel-loaded liposomes. 
  FA-PDCT-L displayed a sustained release profile, promoted 
cell   cytotoxicity, had a stronger apoptotic effect, prolonged 
the systemic circulation time, and achieved higher accumula-
tion in tumoral tissue, thus enhancing the therapeutic action 
of the loading drug. Therefore, the novel polymer FA-PEG-
PCHL and its application in liposomal formulations could 
be a promising solution for delivery of antitumor drugs to 
cancerous tissue.
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